Godsey & Gibb Inc’s MetLife MET Stock Holding History

Godsey & Gibb Inc’s Portfolio MET Stock Details MET Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-160	Closed	-$9.04K	–	357
2023 Q2	$9.04K	Buy	+160	New	+$8.88K	﹤0.01%	276

Other funds holding MET

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Godsey & Gibb Inc's MET Position: Q3 2023 in Review

Godsey & Gibb Inc sold out of MetLife (MET) in Q3 2023, closing a stake of 160 shares — an estimated $9.04K sold.

Godsey & Gibb Inc first reported a position in MET in Q2 2023 and held it in 1 quarter. The position peaked at $9.04K in Q2 2023. 1,180 funds tracked by Wall St. Rank hold MET as of Q3 2023.

Godsey & Gibb Inc reported no remaining MetLife position as of Q3 2023 after selling out during the quarter.
Godsey & Gibb Inc sold 160 MetLife shares in Q3 2023, an estimated $9.04K.
Godsey & Gibb Inc first reported a position in MetLife in Q2 2023 and held it in 1 quarter.
Godsey & Gibb Inc's MetLife position peaked at $9.04K in Q2 2023.
1,180 funds tracked by Wall St. Rank held MetLife as of Q3 2023.

Based on Godsey & Gibb Inc's 13F filing for Q3 2023, filed 25 Oct 2023.